A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

NCT03914443 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

OTHER_GOV

Sponsor class

Conditions

Locally Advanced Esophageal Squamous Cell Carcinoma

Interventions

BIOLOGICAL: Nivolumab
DRUG: 5-FU
DRUG: CDDP
DRUG: DTX

Sponsor

National Cancer Center, Japan

Collaborators

[object Object]
[object Object]